Overview
Lobbying Costs
1,125,000€
Financial year: Jan 2014 - Dec 2014
Lobbyists (Full time equivalent)
4.25 Fte (8)
Lobbyists with EP accreditation
2
High-level Commission meetings
5
Lobbying Costs over the years
-
Info
F. Hoffmann-La Roche Ltd (Roche)
EU Transparency Register
18940431725-51 First registered on 20 May 2009
Goals / Remit
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.
In 2014 the Roche Group employed over 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.Main EU files targeted
- Interactions (direct contacts) with EU Institutions relating to legislation and implementation of EU regulation at national level: e.g. IVD / Medical Devices Regulation, Data Protection Regulation, Clinical Trials Regulation, Horizon 2020/IMI, Pharmaceuticals in the Environment, Falsified Medicines Directive
- Provide input to EU Institutions open consultations, including participation in events sponsored by EU Institutions
- Improve patient safety and strengthen disease prevention in Europe
- Provide coverage and reimbursement that reward innovation
- Increase Europe's competitiveness as a location for Research and Development investment
- Pharmaceuticals, Diagnostics, Diabetes Care, Intellectual Property, TradeAddress
Head Office
Grenzacherstrasse, 124
Basel 4070
SWITZERLAND -
People
Total lobbyists declared
8
Employment time Lobbyists 75% 3 50% 3 25% 2 Lobbyists (Full time equivalent)
4.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
2 accreditations were / are live (in bold) for the selected state of 22 Apr 2015
Name Start date End Date Ludovic LACAINE 11 May 2023 10 May 2024 Luc Etienne FAUQUEX 11 May 2023 10 May 2024 Luc-Etienne Fauquex 24 Apr 2024 23 Apr 2026 Ms Nathalie STIEGER 15 Aug 2019 01 Sep 2020 Ms Nathalie STIEGER 06 Sep 2017 02 Sep 2018 Ms Nathalie STIEGER 22 Aug 2016 05 Aug 2017 Ms Christiane Landsberg 29 Jul 2015 28 Jul 2016 Ms Nathalie STIEGER 21 Jun 2015 18 Jun 2016 Ms Nathalie STIEGER 19 Jun 2014 17 Jun 2015 Ms Sabine Atzor 06 Aug 2014 04 Aug 2015 Mrs Sabine Atzor 06 Aug 2014 27 Jan 2015 Mrs Nathalie STIEGER 19 Jun 2014 27 Jan 2015 Mrs Sabine Atzor 09 Aug 2013 06 Aug 2014 Mrs Nathalie STIEGER 16 Apr 2013 11 Apr 2014 Mrs Nathalie STIEGER 10 Feb 2012 01 Mar 2013 Complementary Information
The current calculation of the number of persons involved relies on a new calculation method following the Guidelines of the Joint Secretariat of the Transparency Register and can therefore NOT be compared to the entry of the previous year.
This new estimate follows and is consistent with the recommendations of the Guidance provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA).Person in charge of EU relations
Ms Nathalie Stieger (Head of Government Affairs)
Person with legal responsibility
Mr Severin Schwan (CEO)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Roche is a member of EFPIA, EDMA and national pharmaceutical and diagnostics associations, EBE, EAPM, Kangaroo Group, AMISA2.
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2014 - Dec 2014
Lobbying costs for closed financial year
1,125,000€
Other financial info
The current estimate of cost relies on a new calculation method following the Guidelines of the Joint Secretariat of the Transparency Register and can therefore NOT be compared to the entry of the previous year.
The cost estimate includes employee activities (calculated as salary cost per FTE on activities within scope as well as pro-rata travel-related costs/office expenses), activities of external professional consultancies, as well as membership fees and sponsoring (to associations etc.).
This new estimate follows and is consistent with the recommendations of the Guidance provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Roche would like to indicate that all entries have been made in line with the greatest possible transparency and are periodically being updated, as soon as e.g. the Joint Secretariat issues new guidelines introducing additional requirements. -
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
None
Other activities
None declared
Meetings
Meetings
5 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 15 Apr 2024 Location Brussels Subject Meeting WEF CEO Action Group for the European Green Deal Cabinet Cabinet of Vice-President Maroš Šefčovič Attending - Maroš Šefčovič (Executive Vice-President)
- Virginie Battu-henriksson (Cabinet member)
Other Lobbyists -
Date 18 Jan 2023 Location Davos, Switzerland Subject EU Innovation Agenda Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Mariya Gabriel (Commissioner)
-
Date 18 Jan 2023 Location Davos, Switzerland Subject EU Innovation Agenda Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Innovation and Youth Attending - Mariya Gabriel (Commissioner)
-
Date 12 Jul 2022 Location video-call Subject Pharmaceutical directive Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Caroline Boeshertz (Cabinet member)
-
Date 13 Oct 2017 Location Mannheim Subject digital policy Cabinet Cabinet of Vice-President Günther Oettinger Portfolio Budget & Human Resources Attending - Günther Oettinger (Commissioner)